The aim of this project is to improve our understanding of the role that increased eye pressure (intraocular pressure or IOP) plays in the development of glaucoma-related nerve death and associated vision loss. Despite being the second leading cause of vision loss in Australia, our understanding of the factors that damage nerves in the eye (the ganglion cells that carry visual information to the brain) in glaucoma remains incomplete. For example, elevated eye pressure is a well-established risk ....The aim of this project is to improve our understanding of the role that increased eye pressure (intraocular pressure or IOP) plays in the development of glaucoma-related nerve death and associated vision loss. Despite being the second leading cause of vision loss in Australia, our understanding of the factors that damage nerves in the eye (the ganglion cells that carry visual information to the brain) in glaucoma remains incomplete. For example, elevated eye pressure is a well-established risk factor for glaucoma, but as many as half of those with glaucoma do not have high eye pressure. Clinical data suggests that pressure fluctuations (or spikes), which go unnoticed in routine clinical check ups, may be involved in glaucoma onset and progression. To date there has been no direct evidence to support this contention. This project aims to use a novel experimental model of pressure elevation in rodents to consider this possibility. By measuring the eye's electrical response to a flash of light it is possible to sensitively assess how pressure spikes, that are known to occur with regularity in humans, might affect the health of retinal ganglion cells. Anatomical measures will also be used to establish the sequence of events that cause cellular damage. This knowledge is an important public health issue, because it will improve understanding of the risk factors for the development of glaucoma. The results may lead to improvements in detection and treatment strategies such as closer monitoring for pressure spikes and more aggressive treatment for those who show greater variability in their eye pressures.Read moreRead less
Improving Inner Retinal Oxygenation: Developing A New Form Of Retinal Laser Photocoagulation Therapy
Funder
National Health and Medical Research Council
Funding Amount
$408,818.00
Summary
Diabetic retinopathy is the major cause of vision loss in the working age population in our community. Current therapy involves laser destruction of much of the peripheral retina to protect the central vision. However, recent clinical and experimental evidence suggests that more moderate laser therapy could be sufficient, and that useful vision in the laser treated area can be preserved. Benefits to the patient would include reduced loss of visual field, and reduced night blindness.
Retinal Endothelial Cell Changes That Precede Retinal Vein Occlusion And The Retinal Extracellular Space Changes That Follow It
Funder
National Health and Medical Research Council
Funding Amount
$118,121.00
Summary
Dr. Min Hye Kang, at The University of Western Australia, is investigating microscopic blood vessel changes that precede the onset of devastating blindness. She is also studying functional changes that occur in the retina following deprivation of its blood supply. Her research has significantly improved our understanding of cellular mechanisms that lead to blindness. It has also aided in the development of new treatment strategies for the prevention of vision loss.
Imaging The Human Fundus To Simultaneously Generate An Oxygenation And Blood Flow Map
Funder
National Health and Medical Research Council
Funding Amount
$565,944.00
Summary
This project aims to exploit a novel solution to a problem which has previously limited the potential for clinical diagnosis and monitoring of ischemic retinal diseases such as diabetic retinopathy. We have devised a method of simultaneously recording blood flow and oxygen saturation level using scanning laser techniques that are readily applicable clinically.
TRAFFICKING OF METABOLITES BETWEEN M LLER CELLS AND NEURONS IN DIABETIC RETINOPATHY.
Funder
National Health and Medical Research Council
Funding Amount
$211,320.00
Summary
Diabetes is the leading cause of blindness in the working population. In some diabetics, blood vessels within the retina proliferate, haemorrhage or cause retinal detachment. The underlying changes within the retina that lead to the proliferation of blood vessels are not well understood. One of the factors that leads to changes in retinal blood vessels is an incease in growth factors from cells in the retina called Muller cells. Muller cells are vital for the normal function of the retina, and a ....Diabetes is the leading cause of blindness in the working population. In some diabetics, blood vessels within the retina proliferate, haemorrhage or cause retinal detachment. The underlying changes within the retina that lead to the proliferation of blood vessels are not well understood. One of the factors that leads to changes in retinal blood vessels is an incease in growth factors from cells in the retina called Muller cells. Muller cells are vital for the normal function of the retina, and are known to be abnromal late in diabetes. They may also be dysfunctional early in diabetes and could play a significant role in the early chnages seen in diabetes. Therefore a good understanding of how Muller cells change and the time at which they change is vitally important to gain a better undetrstanding of the defects that are associated with diabetes. Furthermore, an understanding of the basic underlying cellular changes that occur in diabetes will aid the development of more specific therapeutic agents in the future.Read moreRead less
The Role Of Tau In Experimental Retinal And Optic Nerve Pathology: Relevance To Glaucoma
Funder
National Health and Medical Research Council
Funding Amount
$375,225.00
Summary
Aberrant processing of the axonal protein, tau, is believed to underlie key pathological events in Alzheimer's Disease (AD). Recent data have suggested a link between AD pathology and retinal neuron death in glaucoma. We have further evidence that changes in tau also occur in models of retinal damage. We thus aim to characterise the role of tau in retinal injury models and to relate these findings to glaucoma with a view to having a greater understanding of this disease process.
The Cellular Organisation Of Interneurones In Human Retina
Funder
National Health and Medical Research Council
Funding Amount
$526,454.00
Summary
Our goal is to determine the numbers and types of nerve cells in the human retina: the part of the eye where visual processing starts. This data will serve as a baseline against which effects of visual disease can be measured.
Glial-neuronal-vascular Interactions In A Novel Transgenic Model Of Muller Cell Dysfunction
Funder
National Health and Medical Research Council
Funding Amount
$626,585.00
Summary
Muller cell disfunction is a feature shared by many retinal diseases. This project aims to study the contribution of Muller cell dysfunction to retinal neuronal damage and blood-retinal barrier breakdown in a novel transgenic model we recently generated. Results of this study will also be of interest to scientists and clinicians seeking to understand better and treat diseases of the central nervous system in general.
The Role Of Gliosis In Advanced Retinal Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$457,785.00
Summary
The development of treatments that restore vision assumes that the output neurons of the retina remain intact. Yet, there is now considerable evidence that the neurons that signal from the retina to the brain are altered in those that have degenerative diseases of the retina. Here, we will examine the cause of these cellular changes in an animal model and seek to prevent the loss of output neurons. This information is crucial for the development of treatments that seeks to restore vision.
Novel Functional Imaging For Age-related Macular Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$564,848.00
Summary
Age-related macular degeneration (AMD) is an eye condition which affects the central retina (the macula) resulting in a loss of central vision. The lack of appropriate clinical tests to monitor the progression of AMD at the early stages of disease hampers the discovery of novel interventions aimed at preventing the development of advanced vision-threatening AMD. In this project, we will investigate the use of a quick and non-invasive imaging technique for monitoring AMD progression.